alexa Abstract | Antidiabetic activity of Madhumega Churanam (Siddha formulation) in alloxan induced diabetic rats

Der Pharmacia Sinica
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access

Abstract

The present study was performed to evaluate Siddha formulation for its antidiabetic activity in alloxan (120 mg/kg, i.p.) induced diabetic rats. The effects of Siddha formulation on fasting blood glucose level, body weight, fluid intake cholesterol and triglyceride were studied. Siddha formulation (100 mg/kg/day and 200 mg/kg/day p.o.) was administered to a group of diabetic rats (n=6) for 14 consecutive days and the observed data was compared with glibenclamide (10 mg/ kg/ day p.o.). Administration of churanam causes a significant reduction of blood glucose level (p< 0.001), body weight (p<0.001), fluid intake levels (p<0.001), cholesterol (p<0.001) and triglycerides (p<0.001), vs diabetic control. It can be concluded from the present study that oral administration of Siddha formulation (Madhumega churanam) ameliorated the plasma glucose and lipid levels in alloxan- induced diabetic rats.

To read the full article Peer-reviewed Article PDF image

Author(s): Vadivelan R Umasankar P Dipanjan M Dhanabal SP Shanish A Satishkumar MN and Elanko K

Keywords

Antidiabetic, Siddha formulation, blood glucose, cholesterol, triglycerides

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords